Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria
- PMID: 9600505
- DOI: 10.1016/s0091-6749(98)70176-9
Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria
Erratum in
- J Allergy Clin Immunol 1998 Jul;102(1):156
Abstract
Background: Recent data suggest that a subpopulation of patients with chronic urticaria have an autoimmune disorder that is caused by the presence of antibodies to the IgE receptor. The actual incidence of these antibodies is uncertain.
Objective: We sought to assess the incidence of autoimmunity to the IgE receptor in patients with chronic urticaria and to compare functional and binding assays.
Methods: We isolated skin mast cells and studied a large number of patient sera (68) for their ability to activate these cells and isolated basophils. We then compared the results with those obtained by immunoblotting using cloned alpha-subunit of the IgE receptor.
Results: Sera from patients with chronic urticaria released significant histamine (> 15% of basal) on incubation with basophils (48%) and mast cells (46%). By immunoblotting we obtained positive results in 64% of subjects tested and also identified a small subpopulation that is active on cells but does not bind Fc(epsilon)RIalpha.
Conclusion: Our data suggest that approximately 45% to 50% of patients with chronic urticaria have a cutaneous autoimmune disorder. Immunoblotting may provide a rapid screening method for anti-Fc(epsilon)RIalpha detection in such patients.
Similar articles
-
Mechanisms of autoimmune activation of basophils in chronic urticaria.J Allergy Clin Immunol. 2001 Jun;107(6):1056-62. doi: 10.1067/mai.2001.115484. J Allergy Clin Immunol. 2001. PMID: 11398085
-
Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.J Invest Dermatol. 1996 May;106(5):1001-6. doi: 10.1111/1523-1747.ep12338544. J Invest Dermatol. 1996. PMID: 8618029
-
Assessment of autoimmunity in patients with chronic urticaria.J Allergy Clin Immunol. 1997 Apr;99(4):461-5. doi: 10.1016/s0091-6749(97)70071-x. J Allergy Clin Immunol. 1997. PMID: 9111489
-
Pathogenesis of chronic urticaria.Clin Exp Allergy. 2009 Jun;39(6):777-87. doi: 10.1111/j.1365-2222.2009.03256.x. Epub 2009 Apr 22. Clin Exp Allergy. 2009. PMID: 19400905 Review.
-
Autoimmunity in chronic urticaria and urticarial vasculitis.Curr Allergy Asthma Rep. 2001 Jul;1(4):329-36. doi: 10.1007/s11882-001-0044-0. Curr Allergy Asthma Rep. 2001. PMID: 11892055 Review.
Cited by
-
Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review.Allergy Asthma Clin Immunol. 2020 Aug 4;16:72. doi: 10.1186/s13223-020-00461-x. eCollection 2020. Allergy Asthma Clin Immunol. 2020. PMID: 32944029 Free PMC article. Review.
-
Research hotspots in urticaria: A bibliometric study of the top 100 most cited articles.Skin Res Technol. 2024 May;30(5):e13731. doi: 10.1111/srt.13731. Skin Res Technol. 2024. PMID: 38747942 Free PMC article.
-
Autoimmune urticaria.Clin Rev Allergy Immunol. 2002 Oct;23(2):171-83. doi: 10.1385/CRIAI:23:2:171. Clin Rev Allergy Immunol. 2002. PMID: 12221862 Review.
-
Efficacy of autologous serum therapy in positive and negative autologous serum skin test patients in chronic urticaria in a tertiary care centre.Dermatol Reports. 2022 Jul 6;15(1):9525. doi: 10.4081/dr.2022.9525. eCollection 2023 Mar 7. Dermatol Reports. 2022. PMID: 37034471 Free PMC article.
-
Profile of omalizumab in the treatment of chronic spontaneous urticaria.Drug Des Devel Ther. 2015 Aug 25;9:4909-15. doi: 10.2147/DDDT.S56004. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26346472 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical